Cargando…

Combining DNA-microarray data in systemic lupus erythematosus

Systemic lupus erythematosus is a systemic, heterogeneous autoimmune disease. Understanding of its molecular complexity is incomplete and there is a need to identify new therapeutic targets and to optimize criteria for its diagnosis, assessment and prognosis. Recently, Arasappan and colleagues have...

Descripción completa

Detalles Bibliográficos
Autores principales: Verweij, Cornelis L, Vosslamber, Saskia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219071/
https://www.ncbi.nlm.nih.gov/pubmed/21639954
http://dx.doi.org/10.1186/gm246
_version_ 1782216786012274688
author Verweij, Cornelis L
Vosslamber, Saskia
author_facet Verweij, Cornelis L
Vosslamber, Saskia
author_sort Verweij, Cornelis L
collection PubMed
description Systemic lupus erythematosus is a systemic, heterogeneous autoimmune disease. Understanding of its molecular complexity is incomplete and there is a need to identify new therapeutic targets and to optimize criteria for its diagnosis, assessment and prognosis. Recently, Arasappan and colleagues have described a new meta-analysis method that enables data analysis across different DNA-microarray datasets to identify genes and processes relevant to systemic lupus erythematosus. Their study provides a simple and valuable meta-analysis method for the selection of biomarkers and pathways in disease. See related research by Arasappan et al.: http://www.biomedcentral.com/1741-7015/9/65
format Online
Article
Text
id pubmed-3219071
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32190712011-11-18 Combining DNA-microarray data in systemic lupus erythematosus Verweij, Cornelis L Vosslamber, Saskia Genome Med Research Highlight Systemic lupus erythematosus is a systemic, heterogeneous autoimmune disease. Understanding of its molecular complexity is incomplete and there is a need to identify new therapeutic targets and to optimize criteria for its diagnosis, assessment and prognosis. Recently, Arasappan and colleagues have described a new meta-analysis method that enables data analysis across different DNA-microarray datasets to identify genes and processes relevant to systemic lupus erythematosus. Their study provides a simple and valuable meta-analysis method for the selection of biomarkers and pathways in disease. See related research by Arasappan et al.: http://www.biomedcentral.com/1741-7015/9/65 BioMed Central 2011-05-31 /pmc/articles/PMC3219071/ /pubmed/21639954 http://dx.doi.org/10.1186/gm246 Text en Copyright ©2011 BioMed Central Ltd.
spellingShingle Research Highlight
Verweij, Cornelis L
Vosslamber, Saskia
Combining DNA-microarray data in systemic lupus erythematosus
title Combining DNA-microarray data in systemic lupus erythematosus
title_full Combining DNA-microarray data in systemic lupus erythematosus
title_fullStr Combining DNA-microarray data in systemic lupus erythematosus
title_full_unstemmed Combining DNA-microarray data in systemic lupus erythematosus
title_short Combining DNA-microarray data in systemic lupus erythematosus
title_sort combining dna-microarray data in systemic lupus erythematosus
topic Research Highlight
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219071/
https://www.ncbi.nlm.nih.gov/pubmed/21639954
http://dx.doi.org/10.1186/gm246
work_keys_str_mv AT verweijcornelisl combiningdnamicroarraydatainsystemiclupuserythematosus
AT vosslambersaskia combiningdnamicroarraydatainsystemiclupuserythematosus